THE BEST SIDE OF HEMGENIX

Amount of qualified clients: CDEC reviewed the uncertainty in the quantity of clients with reasonably critical to critical hemophilia B in Canada eligible for etranacogene dezaparvovec. Scientific industry experts consulted by CADTH indicated that some people that are categorized as obtaining gentle or moderate sickness can have a extreme bleeding